US 8658671
Crystalline form of a quinolinone-carboxamide compound
granted A61KA61K31/46A61P
Quick answer
US patent 8658671 (Crystalline form of a quinolinone-carboxamide compound) held by Theravance, Inc. expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/46, A61P, A61P1/00, A61P1/04